rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Roland Wilhelm Kolbeck

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Aclaris Therapeutics.

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
1 Aug 2025
Last trade
1 Aug 2026
Last filed
4 Aug 2026

Companies traded

Where they are an officer
ACRS Aclaris TherapeuticsOfficer · Biotechnology · last 1 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
1 Aug 2026filed 4 Aug 2026ACRS Aclaris TherapeuticsBiotechnologySEC FORM 4 Code M—36,375filing
1 Aug 2026filed 4 Aug 2026ACRS Aclaris TherapeuticsBiotechnologySEC FORM 4 Code F$64K12,385 at $5.20filing
1 Aug 2026filed 4 Aug 2026ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—36,375 at $0.00filing
1 Aug 2026filed 4 Aug 2026ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—36,375 at $0.00filing
1 Aug 2026filed 4 Aug 2026ACRS Aclaris TherapeuticsBiotechnologySEC FORM 4 Code M—36,375filing
1 Aug 2026filed 4 Aug 2026ACRS Aclaris TherapeuticsBiotechnologySEC FORM 4 Code F$64K12,385 at $5.20filing
2 Feb 2026filed 6 Feb 2026ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—95,700 at $0.00filing
2 Feb 2026filed 6 Feb 2026ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—334,900 at $0.00filing
2 Feb 2026filed 6 Feb 2026ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—95,700 at $0.00filing
2 Feb 2026filed 6 Feb 2026ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—334,900 at $0.00filing
1 Aug 2025filed 5 Aug 2025ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—145,500 at $0.00filing
1 Aug 2025filed 5 Aug 2025ACRS Aclaris Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—510,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Andrew N. SchiffDirector · Director at Aclaris Therapeutics, filing Form 4 there in the last year
Vincent MilanoDirector · Director at Aclaris Therapeutics, filing Form 4 there in the last year
Maxine GowenDirector · Director at Aclaris Therapeutics, filing Form 4 there in the last year
Anand MehraDirector · Director at Aclaris Therapeutics, filing Form 4 there in the last year
Christopher P. MolineauxDirector · Director at Aclaris Therapeutics, filing Form 4 there in the last year